Department of nuclear medicine

The department of nuclear medicine at University Hospital of the Ludwig-Maximilians-University (LMU) Munich specializes in diagnosing and treating patients with oncology, neurology, and cardiology disease where nuclear medicine can be used. The department proposes a full range of nuclear medicine diagnostics on 17 cameras, including two 3-headed and several 2-headed gamma cameras and three PET/CT devices. Ambitious technology and excerpt knowledge in nuclear medicine can significantly improve diagnostics and therapy of diseases. One of the focuses of the department is preclinical research, where nuclear physicians, physicists, radiochemists and more specialists provide analysis of the new radiopharmaceuticals in diagnosis and therapy before medical application. The number of inpatient cases is more than 1,000 per year. The department is actively practising and involved in clinical trials in LU-177, Ra-223, Ac-225 and I-131 for neoplasms of different origins.

The doctors of the departments provide diagnostics using radioisotope methods, also known as scintigraphy, positron emission tomography, and SPECT-CT. In oncology, nuclear medicine is used for primary tumour diagnostics, general diagnostics, nuclear therapy (LU-177 PSMA therapy), planning and tumour follow-up.